3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Colorectal Neoplasms
17
Colonic Neoplasms
15
Rectal Neoplasms
11
Stomach Neoplasms
10
Ovarian Neoplasms
6
Neoplasms
5
Gastrointestinal Stromal Tumors
5
Carcinoma, Hepatocellular
5
Uterine Cervical Neoplasms
3
Pancreatic Neoplasms
3
Liver Neoplasms
3
Endometrial Neoplasms
3
Carcinoma, Renal Cell
3
Prostatic Neoplasms
2
Peritoneal Neoplasms
2
Neoplastic Cells, Circulating
2
Kidney Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Esophageal Neoplasms
2
Venous Thrombosis
1
Uterine Neoplasms
1
Surgical Wound Infection
1
Robotic
1
Polycystic Ovary Syndrome
1
Pancreatic Neuroendocrine Tumors
1
Ornithine Carbamoyltransferase Deficiency Disease
1
Obesity, Morbid
1
Neurologic Manifestations
1
Neuroendocrine Tumors
1
Neoplasm Metastasis
1
Interventions
Misoprostol
5
Uterine Myomectomy
4
Saline Solution
3
Hysterectomy
3
dienogest
2
carbetocin
2
Tranexamic Acid
2
Tourniquets
2
Lidocaine
2
Hysteroscopy
2
Ascorbic Acid
2
remimazolam
1
relugolix
1
ramosetron
1
Vasopressins
1
Uterine Artery Embolization
1
Triptorelin Pamoate
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Sodium Chloride
1
Sevoflurane
1
Respiration, Artificial
1
Remifentanil
1
Propofol
1
Population Groups
1
Oxytocin
1
Observation
1
Nuclear Receptor Subfamily 4, Group A, Member 2
1
Morcellation
1
Methylergonovine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Myofibroma
×
Laparoscopy
×
Clear all
NCT06067971
2025-09-12
ENDORA2
University Hospital, Clermont-Ferrand
Phase NA
Completed
40 enrolled